QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Kohnen, Ralf and Urbach, Horst and Stummer, Walter and Glas, Martin (2014) QUALITY OF LIFE AND COGNITIVE FUNCTIONING IN THE RANDOMIZED, MULTICENTER GLARIUS TRIAL INVESTIGATING BEVACIZUMAB/IRINOTECAN VS STANDARD TEMOZOLOMIDE IN NEWLY DIAGNOSED, MGMT-NON-METHYLATED GLIOBLASTOMA PATIENTS. NEURO-ONCOLOGY, 16 (Suppl5). v181. ISSN 1522-8517, 1523-5866

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Neurologie
Depositing User: Petra Gürster
Date Deposited: 13 Aug 2020 13:18
Last Modified: 13 Aug 2020 13:18
URI: https://pred.uni-regensburg.de/id/eprint/9228

Actions (login required)

View Item View Item